Conference abstract · 8 Sep 2014
Conference abstractPublished 23 Nov 2012
ICH Q10: Pharmaceutical quality system
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ICH Q10 describes one comprehensive model for an effective pharmaceutical quality system that is based on International Organization for Standardization (ISO) quality concepts, includes applicable good manufacturing practice (GMP) regulations and complements ICH Q8 ?Pharmaceutical Development? and ICH Q9 ?Quality Risk Management?. It aims to promote a paradigm shift from discrete GMP compliance procedures at each stage of the product life cycle to a comprehensive quality systems approach over the life cycle of the product. It demonstrates industry and regulatory commitment to robust quality systems and technical innovation and enhance assurance of consistent availability of medicines around the world. It?s guidance applies to the systems supporting the development and manufacture of pharmaceutical drug substances and drug products, including biotechnology and biological products. The elements of ICH Q10 should be applied in a manner that is appropriate and proportionate to each of the product life cycle stages, recognizing the differences among and the different goals of each stage. The key objectives are to ? Achieve product realization ? Establish and maintain a state of quality control ? Facilitate continual improvement.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 17 Mar 2025
Stability Testing of Pharmaceutical Products in Compliance with ICH Guidelines
Conference abstract · 14 Mar 2024
Exploring the relevance and considerations of implementing alternative approaches to the assessment of reproductive and developmental toxicity of pharmaceuticals under ICH S5(R3)
Research article · 3 May 2019
Validated stability-indicating RP-HPLC method for tamsulosine hydrochloride in pharmaceutical dosage form according to ICH guidelines: Application to stability studies
Conference abstract · 2 Oct 2017
Mutagenic Impurities in Pharmaceuticals: ICH M7, Purge Factors and the Mirabilis Project
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sandeep Kanna”
- BylineArticles whose byline prints “N. Vishal Gupta”

